scholarly journals Association of secreted insulin with particular domains of the pancreatic B-cell plasma membrane: the actin-rich microvilli.

1992 ◽  
Vol 40 (3) ◽  
pp. 327-331 ◽  
Author(s):  
M Bendayan
Keyword(s):  
Plasma Membrane ◽  
B Cell ◽  
Binding Sites ◽  
Glucose Transporter ◽  
Protein A ◽  
Secretory Activity ◽  
Insulin Binding ◽  
Functional Roles ◽  
Pancreatic B Cell ◽  
Cell Plasma

Association of insulin with the plasma membrane of the pancreatic B-cell was revealed using the high-resolution protein A-gold immunocytochemical approach. The labeling was found to be heterogeneously distributed, the plasma membrane of the actin-rich microvilli being preferentially labeled. Morphometrical evaluation of labeling intensities confirmed the microvilli location of the insulin binding sites. This membrane domain, which also displays the glucose transporter, therefore appears to play important functional roles in the secretory activity of the B-cell. That the autocrine influence insulin exerts on its own secretion is receptor mediated through these insulin binding sites remains, however, to be determined.

Potential mechanism of insulin resistance in ageing: impaired insulin-stimulated glucose transport due to a depletion of the intracellular pool of glucose transporters in Fischer rat adipocytes

1990 ◽  
Vol 126 (1) ◽  
pp. 99-107 ◽  
Author(s):  
S. Matthaei ◽  
H. Benecke ◽  
H. H. Klein ◽  
A. Hamann ◽  
G. Kreymann ◽  
...  
Keyword(s):  
Plasma Membrane ◽  
Glucose Transporter ◽  
Cytochalasin B ◽  
Glucose Transporters ◽  
Insulin Binding ◽  
Low Density ◽  
Intracellular Pool ◽  
Subcellular Membrane ◽  
Impaired Insulin ◽  
In Cells

ABSTRACT To examine the cellular mechanism responsible for impaired insulin action in ageing, we determined various in-vitro parameters involved in the pathogenesis of insulin resistance, i.e. basal and insulin-stimulated [14C]3-O-methylglucose transport (30MG), 125I-labelled insulin binding, activation of insulin receptor kinase (IRKA) in intact cells, and number and subcellular distribution of glucose transporters in subcellular membrane fractions of adipocytes from 6- (FR-6) and 24- (FR-24) month-old Fischer rats. Ageing had no effect on basal 30MG (12±4 vs 13±3 fmol/5 × 104 cells, means ± s.e.m.); in contrast, in FR-24 rats insulin-stimulated 30MG was markedly decreased by 43% when compared with that in FR-6 rats (158±14 vs 90±8 fmol/5 × 104 cells; P < 0·01). Insulin binding to adipocytes from FR-6 rats was 2·40±0·38% compared with 2·28±0·47% in FR-24 (P not significant). Moreover, ageing had no significant effect on IRKA, as determined by insulin-stimulated (0, 1, 4 and 500 ng insulin/ml) 32P-incorporation into histone 2B. In subcellular membrane fractions, low density microsomes and plasma membranes, glucose transporter numbers were determined using [3H]cytochalasin B binding and immunodetection using an antiserum against the C-terminal peptide of the hepatoma-G2-glucose transporter. Cytochalasin B binding revealed that in the basal state the intracellular pool of glucose transporters was depleted in FR-24 by about 39% compared with low density microsomes from FR-6: (48·6±7·2 vs 29·8±5·5 pmol/mg membrane protein; P < 0·01). In consequence, in FR-24 there were fewer glucose transporters available for insulin-induced translocation to the plasma membrane (insulin-treated plasma membrane: 23·9±4·2 (FR-6) vs 14·4±3·1 (FR-24) pmol/mg membrane protein; P < 0·01). These results were confirmed by immunoblotting. In conclusion, (1) maximal insulin-stimulated 30MG was decreased by 43% in cells from FR-24 rats compared with those from FR-6 rats, while basal 30MG was similar in both groups, (2) neither insulin binding nor IRKA were significantly altered in cells from FR-24 rats, and (3) impaired insulin-stimulated 30MG was associated with reduced numbers of glucose transporters in the plasma membrane as a consequence of a depletion of the intracellular pool of glucose transporters in cells from FR-24 rats. Journal of Endocrinology (1990) 126, 99–107

Dexamethasone modulates insulin receptor expression and subcellular distribution of the glucose transporter GLUT 1 in UMR 106-01, a clonal osteogenic sarcoma cell line

1996 ◽  
Vol 17 (1) ◽  
pp. 7-17 ◽  
Author(s):  
D M Thomas ◽  
S D Rogers ◽  
K W Ng ◽  
J D Best
Keyword(s):  
Plasma Membrane ◽  
Insulin Receptor ◽  
Glucose Transport ◽  
Glucose Transporter ◽  
Insulin Binding ◽  
Receptor Expression ◽  
Glut 1 ◽  
Receptor Mrna ◽  
Insulin Receptor Expression ◽  
Umr 106

ABSTRACT Corticosteroids have profound effects on bone metabolism, though the underlying mechanisms remain unclear. They are also known to alter glucose metabolism, in part by induction of insulin resistance. To determine whether corticosteroids impair glucose metabolism in bone cells, we have examined the actions of dexamethasone (DEX) on glucose transport and insulin receptor expression using osteoblast-like UMR 106-01 cells. DEX was shown to inhibit basal 2-deoxyglucose uptake by up to 30% in a time- and dose-dependent manner. It inhibited insulin-stimulated glucose transport by 13%. By Northern and Western blot analysis, DEX was shown to stimulate insulin receptor mRNA and protein by up to 5·6-fold, but it had no effect on expression of the glucose transporter GLUT 1 mRNA or protein under basal conditions. However, DEX augmented insulin-stimulated GLUT 1 mRNA and protein levels. By Scatchard analysis of labelled insulin binding, DEX increased insulin receptor number per cell by 54%. Subcellular fractionation and Western blot analysis demonstrated that DEX caused a redistribution of immunoreactive GLUT 1 from plasma membrane to intracellular microsomes, resulting in a 21% decrease in GLUT 1 at the plasma membrane. These data suggest that (i) DEX impairs basal glucose transport by post-translational mechanisms in UMR 106-01 cells, (ii) DEX increases insulin receptor mRNA, protein and insulin binding and (iii) the inhibition of glucose transport by DEX dominates its effects on the insulin receptor. It is possible that DEX inhibition of glucose transport in osteoblasts may contribute to steroid-induced osteoporosis.

Imidazolines and the Pancreatic B-Cell: Actions and Binding Sites

1999 ◽  
Vol 881 (1 IMIDAZOLINE R) ◽  
pp. 229-240 ◽  
Author(s):  
I. RUSTENBECK ◽  
M. KOPP ◽  
P. RATZKA ◽  
L. LEUPOLT ◽  
A. HASSELBLATT
Keyword(s):  
B Cell ◽  
Binding Sites ◽  
Pancreatic B Cell

scholarly journals B cell activation. III. B cell plasma membrane depolarization and hyper-Ia antigen expression induced by receptor immunoglobulin cross-linking are coupled.

1983 ◽  
Vol 158 (5) ◽  
pp. 1589-1599 ◽  
Author(s):  
J G Monroe ◽  
J C Cambier
Keyword(s):  
Plasma Membrane ◽  
B Cells ◽  
B Cell ◽  
Cell Activation ◽  
Antigen Expression ◽  
Membrane Depolarization ◽  
Cell Surface Expression ◽  
Cross Linking ◽  
Cell Plasma Membrane ◽  
Cell Plasma

We report investigation of the relationship between ligand-induced B cell plasma membrane depolarization and increased expression of membrane-associated, I-A subregion encoded (mI-A) antigens. Results demonstrate that equal frequencies of B cells are stimulated to undergo membrane depolarization and to increase mI-A expression in response to mitogen, anti-Ig, and thymus-independent (TI) or thymus-dependent (TD) antigens. Further, a cause-and-effect relationship between these two events is suggested by results that demonstrate that inhibition of anti-Fab--induced depolarization by valinomycin also inhibits the subsequent increase in mI-A antigen expression and "passive" (non-ligand-mediated) depolarization of murine B cells by K+ results in hyper-mI-A antigen expression. Based upon these results we hypothesize that antigen-mediated receptor cross-linking results in signal transduction via membrane depolarization, which is resultant in increased mI-A antigen synthesis and cell surface expression. This increase in mI-A antigen density may render the B cell more receptive to subsequent interaction with I-region-restricted helper T cells.

Stimulation of glucose transport by thyroid hormone in 3T3-L1 adipocytes: increased abundance of GLUT1 and GLUT4 glucose transporter proteins

2000 ◽  
Vol 164 (2) ◽  
pp. 187-195 ◽  
Author(s):  
R Romero ◽  
B Casanova ◽  
N Pulido ◽  
AI Suarez ◽  
E Rodriguez ◽  
...  
Keyword(s):  
Plasma Membrane ◽  
Glucose Uptake ◽  
Glucose Transport ◽  
Plasma Membranes ◽  
Glucose Transporter ◽  
Fold Increase ◽  
Glucose Transporters ◽  
Insulin Binding ◽  
Total Protein Content ◽  
Glucose Transporter Proteins

In 3T3-L1 adipocytes we have examined the effect of tri-iodothyronine (T(3)) on glucose transport, total protein content and subcellular distribution of GLUT1 and GLUT4 glucose transporters. Cells incubated in T(3)-depleted serum were used as controls. Cells treated with T(3) (50 nM) for three days had a 3.6-fold increase in glucose uptake (P<0.05), and also presented a higher insulin sensitivity, without changes in insulin binding. The two glucose carriers, GLUT1 and GLUT4, increased by 87% (P<0.05) and 90% (P<0. 05), respectively, in cells treated with T(3). Under non-insulin-stimulated conditions, plasma membrane fractions obtained from cells exposed to T(3) were enriched with both GLUT1 (3. 29+/-0.69 vs 1.20+/-0.29 arbitrary units (A.U.)/5 microg protein, P<0.05) and GLUT4 (3.50+/-1.16 vs 0.82+/-0.28 A.U./5 microg protein, P<0.03). The incubation of cells with insulin produced the translocation of both glucose transporters to plasma membranes, and again cells treated with T(3) presented a higher amount of GLUT1 and GLUT4 in the plasma membrane fractions (P<0.05 and P<0.03 respectively). These data indicate that T(3) has a direct stimulatory effect on glucose transport in 3T3-L1 adipocytes due to an increase in GLUT1 and GLUT4, and by favouring their partitioning to plasma membranes. The effect of T(3) on glucose uptake induced by insulin can also be explained by the high expression of both glucose transporters.

scholarly journals Intrauterine Hyperglycemia Increases Insulin Binding Sites but Not Glucose Transporter Expression in Discrete Brain Areas in Term Rat Fetuses

2004 ◽  
Vol 56 (2) ◽  
pp. 263-267 ◽  
Author(s):  
Corinne Leloup ◽  
Christophe Magnan ◽  
Thierry Alquier ◽  
Sanjay Mistry ◽  
Géraldine Offer ◽  
...  
Keyword(s):  
Binding Sites ◽  
Glucose Transporter ◽  
Insulin Binding ◽  
Brain Areas ◽  
Rat Fetuses ◽  
Transporter Expression
Sign in / Sign up

Export Citation Format

Share Document